Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please sign in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception

"Snowball fingers" - Image

Botulinum toxin for the treatment of strabismus: Cochrane systematic review

ACC/AHA: Fewer patients require prophylaxis for endocarditis

Citation

"Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and Other Thromboembolic Events in People With Antiphospholipid Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome.

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome. Accessed January 20, 2019.

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome

Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and Other Thromboembolic Events in People With Antiphospholipid Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case

TY - ELEC T1 - Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome ID - 1305201 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -